Tigecycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-228

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tigecycline (NDC 55150-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg per vial)

Label for Tigecycline for Injection, USP 50 mg per vial in lyophilized powder form for intravenous infusion. The label states the vial contains 50 mg tigecycline and 100 mg lactose monohydrate, with instructions on color of reconstituted solution. Distributed by AuroMedics Pharma LLC, made in India, NDC 55150-228-10.*

FDA Label Image

Package Label-principal Display Panel (50 mg per vial)

Tigecycline 50 mg per vial injection, powder, lyophilized for intravenous infusion by Eugia US LLC (labeler Auromedics Pharma LLC). The packaging is a carton for 10 single-dose vials with clear warnings that the reconstituted solution must be further diluted for intravenous infusion only. Distributed by Auromedics Pharma LLC, made in India.*

FDA Label Image

Tigecycline Chemical Structure (Tigecycline Str)

Chemical structure of tigecycline, depicting the molecular arrangement of atoms and bonds characteristic of this antibiotic compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.